Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Guoxie, a subsidiary of Meihua International Medical Technologies, is actively developing and constructing a comprehensive medical industrial park in the Hainan Free Trade Port (Boao Hope City). This park will integrate manufacturing, R&D, and hospital facilities, focusing on advanced medical devices (surgical robotics, minimally invasive devices), stem cell extraction and storage, and hospital services, including stem cell therapy and elderly wellness. The industrial park is currently under construction (as of October 2025), and no clinical-stage therapeutic results have been reported yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Guoxie Technology Group.